openPR Logo
Press release

19th Annual Cardiology

05-03-2017 03:26 PM CET | Health & Medicine

Press release from: Conference Series LLC

19th Annual Cardiology Conference to be held in Philadelphia, USA during August 31-September 1, 2017 Annual Cardiology 2017 will bring together world-class cardiac professors, cardiac surgeons, cardiologists to discuss strategies for remediation of the disease for the heart, cardiac disorders, research on stem cells in cardiology, cardiac enzyme studies. Cardiology conferences are designed to provide a diversified education and present that will keep medical professionals informed of issues related to the prevention, diagnosis and treatment of cardiovascular disease. This time Cardiology Conference will be organized around the theme "Defining the Future Vision of the Heart."
Heart disease is the leading cause of death for people of most racial/ethnic groups in the United States, Canada, African Americans, Hispanics and Whites. In Canada 90% of people suffering from heart attacks every year and heat attack is the leading cause of death from circulatory diseases in 2009. The Heart and Stroke Foundation of Canada reported that every 7 minutes one person dies from Heart disease/Stroke and the rate of heart diseases and stroke has declined over the past 40 years.
The global economic burden of coronary heart disease is projected to rise from an estimated 47 million disability adjusted life years in 1990 to an estimated 82 million disability adjusted life years by 2020. The Market Research reveals in its new report that increasing global adoption of new medical technologies should drive the demand for cost-effective cardiovascular disease treatment options. The global market for cardiovascular surgical devices is expected to reach nearly $37 billion and $57.2 billion in 2015 and 2020, respectively, reflecting a five-year compound annual growth rate (CAGR) of 9.4%.
Please visit the website for more information: http://cardiac.conferenceseries.com/
Regards,
Priya Darshini R
Program Manager
Annual Cardiology 2017
Ph: 1-702-508-5200 Ext:8033
Email: cardiac@cardiologyconference.org

Conference series LLC
Priya Darshini R
Ph: 1-702-508-5200 Ext:8033

Philadelphia,USA

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release 19th Annual Cardiology here

News-ID: 522623 • Views:

More Releases for Cardiology

05-30-2025 | Health & Medicine
AltuMED
AltuMED Launches Expert Cardiology Billing Services For Cardiology Practices Acr …
BINGHAM FARMS, MI. - AltuMED today introduced specialized Cardiology Billing Services targeting revenue leakage in cardiovascular practices. The Michigan-based RCM innovator addresses critical challenges like complex CPT coding (93458, 93610), ICD-10 compliance (I25.10), and high denial rates that cause U.S. cardiology practices to lose $19B annually. Key solutions include: - AI-powered claim auditing achieving 98% accuracy - Real-time denial tracking reducing rejections by 40% - Custom workflows for cardiac diagnostics/interventions - CMS guideline-compliant billing protocols -
Cardiology Surgical And Interventional Cardiology Devices Market Size by Type, A …
USA, New Jersey- According to Market Research Intellect, the global Cardiology Surgical And Interventional Cardiology Devices market in the Internet, Communication and Technology category is projected to witness significant growth from 2025 to 2032. Market dynamics, technological advancements, and evolving consumer demand are expected to drive expansion during this period. The Cardiology Surgical and Interventional Cardiology Devices market is projected to grow at a CAGR of approximately 7.4% between 2025 and
Cardiology Stem Cells Market - Reviving the Beat: Cardiology Stem Cells Revoluti …
Newark, New Castle, USA: The "Cardiology Stem Cells Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors. Cardiology Stem Cells Market: https://www.growthplusreports.com/report/cardiology-stem-cells-market/8758 This latest report researches the industry structure,
Cardiology Conference 2022
Theme: "Exploring New Research and Frontiers in Heart Care" Heart 2022 welcomes all the eminent professional scholars, researchers and beloved students to be a part of this “INTERNATIONAL CONFERENCE ON CLINICAL CARDIOLOGY & CONGENITAL HEART DISEASE” scheduled on FEBRUARY 07-08, 2022 | PARIS | FRANCE. With individuals from around the world zeroed in on finding a few solutions concerning Cardiology, this is your single most clear chance to achieve the best
World Cardiology Congress
Herald Meetings welcomes you to join World Cardiology Congress scientific symposium will be held in Prague, Czech Republic during August 26 to 27, 2020 About Conferences: WORLD CARDIOLOGY CONGRESS, scheduled on August 26-27, 2020 at Prague, Czech Republic. The conference strives to provide meaningful coverage on the theme "Prediction, Prevention and Cure of Cardiovascular Diseases". Cardiology Congress has established itself as a significant forum for Professors, Cardiology Specialists, Eminent Scientists, and Vascular surgeons,
Cardiology Surgery, Devices and Drugs Market Report 2018: Segmentation by Type ( …
Global Cardiology Surgery, Devices and Drugs market research report provides company profile for St. Jude Medical, Cook Medical, C. R. Bard, Sun Pharmaceutical, Pfizer, Sanofi, AstraZeneca, Novartis, Bristol-Myers Squibb, Merck, Boston Scientific, Medtronic and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and